IDEXX Laboratories, Inc. provided financial guidance for 2024. For the period, The company expects revenue of $3,930 million - $4,040 million. EPS $10.84 - $11.33.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
509.8 USD | +1.80% | +6.08% | -8.15% |
May. 02 | BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653 | MT |
May. 02 | Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675 | MT |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- IDEXX Laboratories, Inc. Provides Financial Guidance for 2024